A new therapeutic option for treatment-resistant depression
Depression can sometimes resist traditional treatments such as antidepressants or psychotherapy.
In such cases, ketamine represents an innovative, scientifically validated approach โ offering new hope for patients.
What is ketamine?
Ketamine has been used for decades as an anesthetic medication.
At low doses and under strict medical supervision, it has shown rapid and significant effects on depressive symptoms,
particularly in cases of treatment-resistant depression.
What makes ketamine different?
- โก Rapid action: noticeable improvement may occur after the first sessions
- ๐ง Distinct mechanism from conventional antidepressants
- ๐ก Effective even for patients who did not respond to traditional treatments
- ๐ฑ Potential reduction of suicidal thoughts in a short period of time
How is the treatment provided at the Canadian Mental Health Center?
- โ
Comprehensive initial evaluation by a psychiatrist
- โ
Definition of a personalized therapeutic plan
- โ
Administration of ketamine via intravenous infusion or nasal spray (depending on medical indication)
- โ
Continuous medical monitoring by a specialized mental health team
- โ
Associated psychotherapeutic follow-up to reinforce treatment benefits
Who can benefit from this treatment?
- Severe or treatment-resistant depression
- Mood disorders with high suicidal risk
- Chronic depressive episodes with major impact on quality of life
Safety and medical supervision
Ketamine is administered exclusively in a secure medical setting, with continuous monitoring to ensure both tolerance and efficacy.
Each patient receives close follow-up to assess progress and adjust the protocol when necessary.
A renewed sense of hope
At the Canadian Mental Health Center, we believe every individual deserves access to the latest medical advances.
Ketamine therapy represents a promising opportunity to rapidly improve the quality of life
of patients for whom traditional approaches have not been sufficient.
